Lyell Immunopharma, Inc.LYELNASDAQ
LOADING
|||
Price to Sales History
Trending lower, above historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
2743.40
↑ 21% above average
Average (5y)
2258.56
Historical baseline
Range
High:6339.02
Low:10.12
CAGR
-15.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 2743.40 | -26.8% |
| 2023 | 3745.44 | +36894.0% |
| 2022 | 10.12 | -94.3% |
| 2021 | 176.41 | -67.1% |
| 2020 | 536.97 | -91.5% |
| 2019 | 6339.02 | - |